EP 3989976 A4 20230719 - LEMBOREXANT FOR TREATING SLEEP ISSUES
Title (en)
LEMBOREXANT FOR TREATING SLEEP ISSUES
Title (de)
LEMBOREXANT ZUR BEHANDLUNG VON SCHLAFSTÖRUNGEN
Title (fr)
LEMBOREXANT POUR LE TRAITEMENT DE PROBLÈMES DE SOMMEIL
Publication
Application
Priority
- US 2019039333 W 20190626
- US 2019006795 W 20191220
- US 2020039674 W 20200625
IPC 8 full level
A61K 31/519 (2006.01); A61K 45/06 (2006.01); A61P 25/20 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP IL)
A61K 31/506 (2013.01 - EP IL); A61P 25/20 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 43/00 (2017.12 - EP IL)
Citation (search report)
- [XY] MARGARETMOLINE ET AL: "EFFICACY AND TOLERABILITY OF LEMBOREXANT IN FEMALE AND MALE SUBJECTS WITH INSOMNIA EFFECT OF LEMBOREXANT ON SLEEP ARCHITECTURE IN OLDER ADULTS WITH INSOMNIA DISORDER", SLEEP, 1 January 1201 (1201-01-01), pages a150 - a151, XP093053299
- [XY] MURPHY PATRICIA ET AL: "Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study", JOURNAL OF CLINICAL SLEEP MEDICINE, vol. 13, no. 11, 15 November 2017 (2017-11-15), US, pages 1289 - 1299, XP055778847, ISSN: 1550-9389, DOI: 10.5664/jcsm.6800
- See references of WO 2020264201A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
DOCDB simple family (application)
EP 20832928 A 20200625